Search details
1.
Targeting chemoresistance in Xp11.2 translocation renal cell carcinoma using a novel polyamide-chlorambucil conjugate.
Cancer Sci
; 113(7): 2352-2367, 2022 Jul.
Article
in English
| MEDLINE | ID: mdl-35396773
2.
RUNX1 transactivates BCR-ABL1 expression in Philadelphia chromosome positive acute lymphoblastic leukemia.
Cancer Sci
; 113(2): 529-539, 2022 Feb.
Article
in English
| MEDLINE | ID: mdl-34902205
3.
Chlorambucil-conjugated PI-polyamides (Chb-M'), a transcription inhibitor of RUNX family, has an anti-tumor activity against SHH-type medulloblastoma with p53 mutation.
Biochem Biophys Res Commun
; 620: 150-157, 2022 09 10.
Article
in English
| MEDLINE | ID: mdl-35792512
4.
CD146 is a potential immunotarget for neuroblastoma.
Cancer Sci
; 112(11): 4617-4626, 2021 Nov.
Article
in English
| MEDLINE | ID: mdl-34464480
5.
Albendazole induces the terminal differentiation of acute myeloid leukaemia cells to monocytes by stimulating the Krüppel-like factor 4-dihydropyrimidinase-like 2A (KLF4-DPYSL2A) axis.
Br J Haematol
; 194(3): 598-603, 2021 08.
Article
in English
| MEDLINE | ID: mdl-34227104
6.
Suppression of malignant rhabdoid tumors through Chb-M'-mediated RUNX1 inhibition.
Pediatr Blood Cancer
; 68(2): e28789, 2021 02.
Article
in English
| MEDLINE | ID: mdl-33180377
7.
Role of RUNX1 in hematological malignancies.
Blood
; 129(15): 2070-2082, 2017 04 13.
Article
in English
| MEDLINE | ID: mdl-28179279
8.
Genetic compensation of RUNX family transcription factors in leukemia.
Cancer Sci
; 109(8): 2358-2363, 2018 Aug.
Article
in English
| MEDLINE | ID: mdl-29883054
9.
Corrigendum to "Chlorambucil-conjugated PI-polyamide (Chb-M'), a transcription inhibitor of the RUNX family, has anti-tumor activity against SHH-type medulloblastoma with p53 mutation" [Biochem. Biophys. Res. Commun. 620 (10 September 2022) 150-157].
Biochem Biophys Res Commun
; 656: 146-147, 2023 May 14.
Article
in English
| MEDLINE | ID: mdl-36966045
10.
Blast cells in acute megakaryoblastic leukaemia with Down syndrome are characterized by low CLEC12A expression.
Br J Haematol
; 192(1): e7-e11, 2021 01.
Article
in English
| MEDLINE | ID: mdl-33095915
11.
CXCR4 Overexpression is a Poor Prognostic Factor in Pediatric Acute Myeloid Leukemia With Low Risk: A Report From the Japanese Pediatric Leukemia/Lymphoma Study Group.
Pediatr Blood Cancer
; 63(8): 1394-9, 2016 08.
Article
in English
| MEDLINE | ID: mdl-27135782
12.
Intravenous immunoglobulin enhances the killing activity and autophagy of neutrophils isolated from immunocompromised patients against multidrug-resistant bacteria.
Biochem Biophys Res Commun
; 464(1): 94-9, 2015 Aug 14.
Article
in English
| MEDLINE | ID: mdl-26119690
13.
The C-terminus of CBFß-SMMHC is required to induce embryonic hematopoietic defects and leukemogenesis.
Blood
; 121(4): 638-42, 2013 Jan 24.
Article
in English
| MEDLINE | ID: mdl-23152542
14.
KIT with D816 mutations cooperates with CBFB-MYH11 for leukemogenesis in mice.
Blood
; 119(6): 1511-21, 2012 Feb 09.
Article
in English
| MEDLINE | ID: mdl-22160378
15.
Generation of induced pluripotent stem cells from primary chronic myelogenous leukemia patient samples.
Blood
; 119(26): 6234-42, 2012 Jun 28.
Article
in English
| MEDLINE | ID: mdl-22592606
16.
Loss of AML1/Runx1 accelerates the development of MLL-ENL leukemia through down-regulation of p19ARF.
Blood
; 118(9): 2541-50, 2011 Sep 01.
Article
in English
| MEDLINE | ID: mdl-21757616
17.
Cbfb/Runx1 repression-independent blockage of differentiation and accumulation of Csf2rb-expressing cells by Cbfb-MYH11.
Blood
; 115(7): 1433-43, 2010 Feb 18.
Article
in English
| MEDLINE | ID: mdl-20007544
18.
A RUNX-targeted gene switch-off approach modulates the BIRC5/PIF1-p21 pathway and reduces glioblastoma growth in mice.
Commun Biol
; 5(1): 939, 2022 09 09.
Article
in English
| MEDLINE | ID: mdl-36085167
19.
RUNX1-Survivin Axis Is a Novel Therapeutic Target for Malignant Rhabdoid Tumors.
Mol Cells
; 45(12): 886-895, 2022 Dec 31.
Article
in English
| MEDLINE | ID: mdl-36572559
20.
Crk-associated substrate lymphocyte type regulates myeloid cell motility and suppresses the progression of leukemia induced by p210Bcr/Abl.
Cancer Sci
; 102(12): 2109-17, 2011 Dec.
Article
in English
| MEDLINE | ID: mdl-21848808